Maxim analyst Jason McCarthy reiterated a Hold rating on shares of pharmaceutical giant Gilead Sciences, Inc (NASDAQ:GILD), after discussing with GILD management about the …
Analysts provide insights on healthcare giants Celgene Corporation (NASDAQ:CELG) and Johnson & Johnson (NYSE:JNJ), following an amended agreement and an investor day, respectively. One …
By Brett Eversole Quality companies are going on sale. Investors are scared.
Once upon a time, high dividend stocks tended to trade at discounts to the rest of the market. Today?
Blink and you miss it? The broader market is already on its way to recovering after the recent volatility.
The Dividend Diplomats were at it again! We both had bought the same company on Tuesday June 16th and we couldn’t be …
This is an article that I’m putting together based on reader feedback. You speak (or comment, I should say) and I listen …
Achillion Pharmaceuticals, Inc. Early in the week, we saw Achillion Pharmaceuticals, Inc.
Biotechnology company Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) fell about 10% in trading on Wednesday, May 20 following the company’s announcement that it licensed its …
This is not an invitation to buy or sell this security. Do your own research and come to your own conclusions.
